Evaluating the safety and feasibility of prophylactic third-party NK cell administration in high-risk AML patients post-HSCT
评估在造血干细胞移植后高危急性髓系白血病（AML）患者中预防性第三方NK细胞输注的安全性和可行性。
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-15362-8
Barkhordar, Maryam; Tavoosi, Shima; Tavakoli, Shirin; Salavatipour, Maryam Samareh; Bahri, Tanaz; Chahardouli, Bahram; Baghsheikhi, Amir Hossein; Vaezi, Mohammad; Babakhani, Davoud; Rad, Soroush; Mousavi, Seied Asadollah; Janbabai, Ghasem; Salehi-Shadkami, Hossein; Ahmadvand, Mohammad
